Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
The Journal of Steroid Biochemistry and Molecular Biology
Sharmin NadkarniAndrzej Kutner
International Journal of Molecular Sciences
Matan NachlielyMichael Danilenko
Cancer Chemotherapy and Pharmacology
Joanna WietrzykAndrzej Kutner
The Journal of Steroid Biochemistry and Molecular Biology
Silvia VinhasRita Sigüeiro
Magnetic Resonance in Chemistry : MRC
E BednarekL Kozerski